Chile vs Oman: New cases tested for RR-/MDR-TB
Chile
100.0%
in 2024
Oman
100.0%
in 2024
Chile rank
1st
Oman rank
1st
New cases tested for RR-/MDR-TB over time
- Chile
- Oman
How they compare
Chile currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 4 times across 20 shared years of data; in 2005 it was Oman ahead.
Chile ranks 1st and Oman ranks 1st of 192 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Oman in 2.
Head to head by decade
| Decade | Chile | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.1% | 71.2% | 67.1% | Oman |
| 2010s | 53.6% | 95.9% | 42.3% | Oman |
| 2020s | 95.2% | 91.2% | 4.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Chile or Oman?
- Chile, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Chile and Oman?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Oman?
- 20 years are reported by both, from 2005 to 2024.
- How do Chile and Oman rank globally for new cases tested for rr-/mdr-tb?
- Chile ranks 1st and Oman ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.